These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19265689)

  • 1. The (mis) use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jaw.
    Don-Wauchope AC; Cole DE
    Clin Biochem; 2009 Jul; 42(10-11):1194-6. PubMed ID: 19265689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
    Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.
    Lee CY; Suzuki JB
    Implant Dent; 2009 Dec; 18(6):492-500. PubMed ID: 20009603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaw and bisphosphonates: a comparison with white phosphorus, radium, and osteopetrosis.
    Vance MA
    Clin Toxicol (Phila); 2007; 45(7):753-62. PubMed ID: 17852160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages and disadvantages of the use of bisphosphonates in oral and maxillofacial surgery.
    de Souza Loureiro CC; Leandro LF
    Int Dent J; 2010 Aug; 60(4):263-8. PubMed ID: 20949756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic studies are needed to clarify whether dental modalities could be predictors of bisphosphonate osteonecrosis of the jaw in breast cancer patients.
    Kyrgidis A; Andreadis C
    Oncologist; 2009 Jan; 14(1):101-2; author reply 103. PubMed ID: 19182244
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
    Sarasquete ME; González M; San Miguel JF; García-Sanz R
    Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and osteonecrosis: potential treatment or serious complication?
    Goytia RN; Salama A; Khanuja HS
    Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
    Body JJ; Coleman R; Clezardin P; Ripamonti C; Rizzoli R; Aapro M;
    Eur J Cancer; 2007 Mar; 43(5):852-8. PubMed ID: 17258449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw: who gets it, and why?
    Reid IR
    Bone; 2009 Jan; 44(1):4-10. PubMed ID: 18948230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle.
    Bertoldo F; Santini D; Lo Cascio V
    Nat Clin Pract Oncol; 2007 Dec; 4(12):711-21. PubMed ID: 18037875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.